Results 221 to 230 of about 49,721 (234)

Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer

Annals of Oncology, 2013
M A Socinski, V Hirsh, M A Socinski
exaly  

nab-Paclitaxel auch langfristig erfolgreich

Info Onkologie, 2015
openaire   +1 more source

Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model

Molecular Pharmaceutics, 2019
Thierry Lecomte, Alban Girault, Ayache Bouakaz   +2 more
exaly  

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

Case Medical Research, 2019
openaire   +1 more source

Nab-Paclitaxel: A Novel Formulation of Taxane for Treatment of Breast Cancer

Women's Health, 2010
Vivek Roy, Prakash Vishnu
exaly  

Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval

OncoTargets and Therapy, 2011
Yutaka Yamamoto
exaly  

Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes

European Journal of Cancer, 2016
Liza Villaruz
exaly  

nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer

Cancer Treatment Reviews, 2014
Sara Hurvitz
exaly  

[FOLFIRINOX, nab-paclitaxel + gemcitabine].

Nihon rinsho. Japanese journal of clinical medicine, 2015
openaire   +1 more source

Nab-paclitaxel licensed for advanced pancreatic cancer

The Pharmaceutical Journal, 2014
openaire   +1 more source